Pharmaceutical products for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of prostate cancer; androgen biosynthesis inhibitors in the nature of pharmaceutical preparations for use in oncology; androgen biosynthesis inhibitors in the nature of pharmaceutical preparations for the treatment of cancer; androgen biosynthesis inhibitors in the nature of pharmaceutical preparations for the treatment of prostate cancer; pharmaceutical ...